Human endotoxemia and human sepsis: limits to the model
- PMID: 15774069
- PMCID: PMC1175943
- DOI: 10.1186/cc3501
Human endotoxemia and human sepsis: limits to the model
Abstract
Sepsis remains the most common cause of death in intensive care units of the developed world. Accurate models of this disease syndrome are crucial for to the understanding of the complex pathophysiology of this disorder. The administration of a small dose of lipopolysaccharide to healthy volunteers is one such model of spontaneous human sepsis. Although this human endotoxemia model appears to be reasonably effective in mimicking early biochemical, metabolic, hematologic and cardiovascular septic responses in septic shock, the ability to mimic other aspects of human sepsis is open to question. The current study demonstrates that human experimental endotoxemia fails to generate evidence of increased vascular permeability within the relatively short time frame of the study.
Comment on
-
Microvascular permeability during experimental human endotoxemia: an open intervention study.Crit Care. 2005 Apr;9(2):R157-64. doi: 10.1186/cc3050. Epub 2005 Feb 21. Crit Care. 2005. PMID: 15774049 Free PMC article.
References
-
- Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock. 1998;9:1–11. - PubMed
-
- Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA, Jr, Cerami A, Shires GT, Lowry SF. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet. 1988;166:147–153. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
